# FMC Corp: Form 10-Q for the period ended Sep 30, 2018

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2018-11-06
- Accepted by EDGAR: Nov 6, 2018, 16:12 ET
- Period: 2018-09-30
- Accession: 0000037785-18-000076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778518000076/fmc09301810q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778518000076/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $1.04bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $3.51bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $589.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.96bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $446.2m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $1.54bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2018-07-01 to 2018-09-30 | $207.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-01-01 to 2018-09-30 | $619.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $141.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $682.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | $30.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $100.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-07-01 to 2018-09-30 | $72.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-01-01 to 2018-09-30 | $469.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-30 | $3.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.54 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | $3.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-30 | 136,357,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-30 | 136,237,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | $460.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $88.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-01-01 to 2018-09-30 | $66.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2018-09-30 | $176.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $3.49bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $9.41bn | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $2.27bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-09-30 | $2.59bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-09-30 | $83.6m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2018-09-30 | $65.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2018-09-30 | $3.05bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2018-09-30 | 134,657,913 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 70,967 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expect”, “expects”, “should”, “could”, “may”, “will continue to”, “believe”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2017 (the “2017 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2017 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2017 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Revenue recognition and trade receivables
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets and indefinite-lived assets
- Pensions and other postretirement benefits
- Income taxes

On January 1, 2018, ASU 2014-09, *Revenue from Contracts with Customers,* became effective. See Note 2 for more information. Our revenue recognition and trade receivables critical accounting policy has been updated in order to comply with the accounting standard update.

Revenue from product sales is recognized when (or as) FMC satisfies a performance obligation by transferring the promised goods to a customer; that is, when control of the good transfers to the customer. In determining when the control of goods is transferred, we typically assess, among other things, the transfer of risk and title and the shipping terms of the contract. The transfer of title and risk typically occurs either upon shipment to the customer or upon receipt by the customer. As such, FMC typically recognizes revenue when goods are shipped based on the relevant incoterm for the product order, or in some regions, when delivery to the customer’s requested destination has occurred (regardless of shipping terms). When we perform shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. For FOB shipping point terms, revenue is recognized at the time of shipment since the customer gains control at this point in time. We exclude from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by us from a customer for (e.g. sales tax, value added tax, etc.) We record a liability until remitted to the respective taxing authority.

As a part of our customary business practice, we offer a number of sales incentives to our customers including volume discounts and rebates, primarily in our FMC Agricultural Solutions segment. For all such contracts that include any variable consideration, we estimate the variable consideration and factor in such an estimate while determining the transaction price (i.e., the price we expect to be entitled to under the contract). Incentives due to customers are accrued as a reduction of revenue in the same period the related sales are recorded based on the contract terms.

FMC periodically enters into prepayment arrangements with customers, and receives advance payments for product to be delivered in future periods. Prepayment terms are extended to customers/distributors in order to capitalize on surplus cash with growers. Growers receive bulk payments for their produce, which they leverage to buy our products from distributors through prepayment options. This in turn creates opportunity for distributors to make large prepayments to us for securing the future supply of products to be sold to growers. The intent of such payments is not to receive the provision of finance from FMC. Additionally, prepayments are typically received in the fourth quarter of the fiscal year and are for the following marketing year indicating that the time difference between prepayment and performance of corresponding performance obligations does not exceed one year.

Trade receivables consist of amounts owed from customer sales and are recorded when revenue is recognized. The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we use a two-stage process which includes calculating a general formula to develop an allowance to appropriately address the uncertainty surrounding collection risk of our entire portfolio and specific allowances for customers where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions.

Our method of calculating the general formula consists of estimating the recoverability of trade receivables based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. Our analysis of trade receivable collection risk is performed quarterly, and the allowance is adjusted accordingly.

We also hold long-term receivables that represent long-term customer receivable balances related to past-due accounts which are not expected to be collected within the current year. Our policy for the review of the allowance for these receivables is consistent with the discussion in the preceding paragraph above on trade receivables. Therefore, on an ongoing basis, we continue to evaluate the credit quality of our long-term receivables utilizing aging of receivables, collection experience and write-offs, as well as existing economic conditions, to determine if an additional allowance is necessary.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in two distinct business segments: FMC Agricultural Solutions and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis application.

### Third Quarter 2018 Highlights

The following are the more significant developments in our businesses during the three months ended September 30, 2018:

- Revenue of $1,035.6 million for the three months ended September 30, 2018 increased $389.4 million or 60 percent versus the same period last year. The increase in revenue was primarily attributable to FMC Agricultural Solutions and the acquisition of the DuPont Crop Protection Business, which was completed in November 2017. A more detailed review of revenue by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America increased by 120 percent, sales in Asia increased 84 percent, sales in Latin America increased 31 percent, and sales in Europe, Middle East and Africa increased by 46 percent.
- Our gross margin, excluding transaction-related charges, of $447.5 million increased versus the prior year's third quarter by $181.6 million. Gross margin percent, excluding transaction-related charges, of 43 percent also increased compared to 41 percent in the prior year primarily due to higher margin products within FMC Agricultural Solutions and, to a lesser extent, higher prices in FMC Lithium.
- Selling, general and administrative expenses, excluding transaction-related charges, increased by approximately $78.2 million or 74 percent to $183.9 million primarily due to the acquisition of the DuPont Crop Protection Business, which is being integrated into our FMC Agricultural Solutions segment.
- Research and development expenses of $70.9 million increased $40.7 million or approximately 135 percent. The increase was due to investments in discovery and product development from the state of the art facilities acquired from the DuPont Crop Protection Business Acquisition.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $134.1 million increased compared to the prior year amount of $95.4 million primarily due to higher results in both FMC Agricultural Solutions and FMC Lithium. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

On October 15, 2018, Livent closed on its IPO. After completion of the IPO, FMC owned 123 million shares of Livent's common stock, representing approximately 85 percent of the total outstanding shares of Livent's common stock. FMC presently intends to distribute the remaining Livent shares on March 1, 2019. We will continue to consolidate Livent as the FMC Lithium reporting segment until the full separation date. At that time, results of Livent will move to discontinued operations. As of, and through, September 30, 2018, Livent was wholly owned by us and is reported as FMC Lithium in these condensed consolidated financial statements.

### RESULTS OF OPERATIONS

### Overview

Our segment operating results are presented based on how we assess operating performance and internally report financial information. For management purposes, we report the operating performance of each of our business segments based on earnings before interest, income taxes, and depreciation and amortization excluding corporate expenses, other income (expense), net and corporate special income (charges).

*(in Millions)*

| 2018 Revenue | Three Months Ended September 30, | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $923.6 | $551.8 | $3,185.9 | $1,665.0 |
| FMC Lithium | 112.0 | 94.4 | 322.7 | 234.0 |
| **Total** | **$1,035.6** | **$646.2** | **$3,508.6** | **$1,899.0** |
| **Earnings before interest, taxes and depreciation and amortization (EBITDA)** |  |  |  |  |
| FMC Agricultural Solutions | $216.2 | $137.3 | $916.1 | $352.7 |
| FMC Lithium | 48.6 | 40.2 | 150.1 | 93.7 |
| Corporate and other | (29.7) | (22.4) | (80.5) | (69.5) |
| **Operating profit before the items listed below** | **$235.1** | **$155.1** | **$985.7** | **$376.9** |
| Depreciation and amortization | (42.4) | (25.1) | (124.7) | (71.2) |
| Interest expense, net | (33.4) | (18.4) | (101.7) | (51.3) |
| Restructuring and other (charges) income (1) | (25.9) | (7.1) | (29.2) | (22.3) |
| Non-operating pension and postretirement (charges) income (2) | 1.2 | 3.6 | 0.5 | 12.3 |
| Transaction-related charges (3) | (25.0) | (48.8) | (149.1) | (78.7) |
| (Provision) benefit for income taxes | (30.1) | 11.6 | (100.4) | (1.1) |
| Discontinued operations, net of income taxes | (4.7) | (15.1) | (4.2) | (157.3) |
| Net income attributable to noncontrolling interests | (2.0) | (0.6) | (7.2) | (1.6) |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | **$72.8** | **$55.2** | **$469.7** | **$5.7** |

(1) See Note 9 for details of restructuring and other (charges) income. Below provides the detail of the (charges) income by segment:

*(in Millions)*

|  | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $(22.0) | $(2.2) | $(13.9) | $(7.0) |
| FMC Lithium | (0.3) | — | (2.4) | (2.7) |
| Corporate | (3.6) | (4.9) | (12.9) | (12.6) |
| **Restructuring and other (charges) income** | **$(25.9)** | **$(7.1)** | **$(29.2)** | **$(22.3)** |

(2) Our non-operating pension and postretirement charges (income) are defined as those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our segments results and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our Adjusted Earnings results noted above. These elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

(3) Charges relate to the expensing of the legal and professional third-party fees associated with acquisitions and separation activities. Amounts represent the following:

*(in Millions)*

| Transaction-related charges Acquisition-related charges - DuPont Crop | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Legal and professional fees (1) | $16.9 | $48.8 | $64.7 | $78.7 |
| Inventory fair value amortization (2) | 1.3 | — | 69.6 | — |
| **Separation-related charges - FMC Lithium** |  |  |  |  |
| Legal and professional fees (1) | $6.8 | $— | $14.8 | $— |
| **Total Transaction-related charges** | **$25.0** | **$48.8** | **$149.1** | **$78.7** |

(1) Represents transaction costs, costs for transitional employees, other acquired employees related costs, and transactional-related costs such as legal and professional third-party fees. These charges are recorded as a component of “Selling, general and administrative expense" on the condensed consolidated statements of income (loss).

(2) These charges are recorded as a component of "Costs of sales and services" on the condensed consolidated statements of income (loss).

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income (loss) attributable to FMC stockholders.” We believe that this measure provides useful information about our operating results to investors. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2018 | Three Months Ended September 30, | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | $72.8 | $55.2 | $469.7 | $5.7 |
| Corporate special charges (income), pre-tax (1) | 49.7 | 52.3 | 177.8 | 88.7 |
| Income tax expense (benefit) on Corporate special charges (income) (2) | (10.4) | (17.9) | (40.3) | (30.4) |
| Corporate special charges (income), net of income taxes | $39.3 | $34.4 | $137.5 | $58.3 |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | 4.7 | 15.2 | 4.2 | 157.4 |
| Non-GAAP tax adjustments (3) | 17.3 | (9.4) | 15.4 | (2.8) |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | **$134.1** | **$95.4** | **$626.8** | **$218.6** |

(1) Represents restructuring and other charges (income), non-operating pension and postretirement charges (income) and transaction-related charges.

(2) The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the Corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure.

(3) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to current year ongoing business operations; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law which includes the impact of the Act enacted on December 22, 2017. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment EBITDA is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses, research and development expenses), excluding depreciation and amortization. We have excluded the following items from segment EBITDA: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, transaction-related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 19 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2017 Form 10-K.

### FMC Agricultural Solutions

*(in Millions)*

| 2018 | Three Months Ended September 30, | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Segment Revenue | $923.6 | $551.8 | $3,185.9 | $1,665.0 |
| Segment EBITDA | 216.2 | 137.3 | 916.1 | 352.7 |

### Three Months Ended September 30, 2018 vs. 2017

Revenue of $923.6 million increased $371.8 million, or approximately 67 percent versus the prior year quarter. The increase was primarily due to the revenue from the DuPont Crop Protection Acquisition, which was completed on November 1, 2017, and contributed approximately $405 million of the increase.

Segment EBITDA of $216.2 million increased by $78.9 million, or approximately 57 percent, compared to the prior year quarter. The increase was primarily driven by the addition of the results from the acquired DuPont Crop Protection Business.

### Nine Months Ended September 30, 2018 vs. 2017

Revenue of $3,185.9 million increased $1,520.9 million, or approximately 91 percent versus the prior year period. The increase was primarily due to the revenue from the DuPont Crop Protection Acquisition, which was completed on November 1, 2017, and contributed approximately $1,532 million of the increase.

Segment EBITDA of $916.1 million increased by $563.4 million, or approximately 160 percent, compared to the prior year period. The increase was primarily driven by the addition of the results from the acquired DuPont Crop Protection Business.

Refer to the *FMC Agricultural Solutions Pro Forma Financial Results with the DuPont Crop Protection Business* section below for further discussion.

### FMC Agricultural Solutions Pro Forma Financial Results with the DuPont Crop Protection Business

We began to present pro forma combined results for the FMC Agricultural Solutions segment in the first quarter of 2018. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the DuPont Crop Protection Business Acquisition had occurred on January 1, 2017. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for costs related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated the DuPont Crop Protection Business since January 1, 2017, nor our future results.

*FMC Agricultural Solutions Pro Forma Financial Results*

*(in Millions)*

| Revenue | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Revenue, FMC Agricultural Solutions, as reported (1) | $923.6 | $551.8 | $3,185.9 | $1,665.0 |
| Revenue, DuPont Crop Protection Business, pro forma (2) | — | 328.4 | — | 1,261.7 |
| **Pro Forma Combined, Revenue (3) (4)** | **$923.6** | **$880.2** | **$3,185.9** | **$2,926.7** |
| **EBITDA** |  |  |  |  |
| EBITDA, FMC Agricultural Solutions, as reported (1) | $216.2 | $137.3 | $916.1 | $352.7 |
| EBITDA, DuPont Crop Protection Business, pro forma (2) | — | 99.1 | — | 488.2 |
| **Pro Forma Combined, EBITDA (3) (4)** | **$216.2** | **$236.4** | **$916.1** | **$840.9** |

(1) As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the DuPont Crop Protection Acquisition from November 1, 2017 onward.

(2) DuPont Crop Protection Business pro forma amounts include the historical results of the DuPont Crop Protection Business, prior to November 1, 2017. These amounts also include adjustments as if the DuPont Crop Protection Business Acquisition had occurred on January 1, 2017, including the effects of acquisition accounting. The pro forma amounts do not include adjustments for expenses related to integration activities, cost savings or synergies that may have been or may be achieved by the combined segment.

(3) The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired the DuPont Crop Protection Business on January 1, 2017 or indicative of future results.

(4) For the three and nine months ended September 30, 2018, pro forma results and actual results are the same.

*FMC Agricultural Solutions Pro Forma Combined Revenue by Region (1) (2)*

*(in Millions)*

|  | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| North America (3) | $201.8 | $153.2 | $842.0 | $727.4 |
| Europe, Middle East and Africa (EMEA) (4) | 133.5 | 161.0 | 826.1 | 804.9 |
| Latin America (5) | 379.0 | 346.9 | 737.3 | 650.2 |
| Asia (6) | 209.3 | 219.1 | 780.5 | 744.2 |
| **Total FMC Agricultural Solutions Revenue** | **$923.6** | **$880.2** | **$3,185.9** | **$2,926.7** |

(1) For the three and nine months ended September 30, 2018, pro forma results and actual results are the same.

(2) Combined revenue by region for the three and nine months ended September 30, 2017 includes the results of the DuPont Crop Protection Business of approximately $328 million and $1,262 million, respectively, assuming the acquisition occurred on January 1, 2017. These amounts include adjustments as if the DuPont Crop Protection Business Acquisition had occurred on January 1, 2017. The pro forma combined revenue by region amounts are not necessarily indicative of what the results would have been had we acquired the DuPont Crop Protection Business on January 1, 2017 or indicative of future results.

(3) Increase in the three and nine months ended September 30, 2018 was due to volume growth of acquired products, strong demand from new herbicide products, and planted acres increasing for wheat, cotton and rice. These were partially offset by unfavorable weather during the period as well as unfavorable impacts from the delayed start to the season.

(4) Decrease in the three months ended September 30, 2018 was due to warm and dry conditions affecting demand for herbicides and fungicides as well as timing of orders in both Belgium and Holland that will push sales into the fourth quarter due to the shift to a direct market access in those countries. Increase in the nine months ended September 30, 2018 was due to synergies contributing to higher sales particularly in insecticides partially offset by a shorter growing season and lower yields in Northern and Central Europe due to poor weather conditions.

(5) Increase in the three months ended September 30, 2018 was primarily due to strong growth in cotton acreage and market growth in Brazil, partially offset by unfavorable foreign currency impacts. Increase in the nine months ended September 30, 2018 was driven by the volume growth in soybean crop, growth in cotton acreage, and market growth in Brazil and Mexico.

(6) Decrease for the three months ended September 30, 2018 was due to the rationalization of the legacy portfolio in India and unfavorable foreign currency impacts, partially offset by the strong performance in rice and soy insecticides in India. Increase for the nine months ended September 30, 2018 was due to strong performance in rice and soy insecticides in India and growth in rice herbicides in China which was partially offset by extreme drought conditions in Australia and divestment of the legacy portfolio in India.

### Pro Forma Combined Results - Three Months Ended September 30, 2018 vs. 2017

Pro forma combined revenue of $923.6 million increased by approximately 5 percent versus the prior year quarter. Refer to the *FMC Agricultural Solutions Pro Forma Combined Revenue by Region* chart above for further discussion.

Pro forma combined segment EBITDA of $216.2 million decreased approximately 9 percent compared to the prior year quarter. The decrease was primarily driven by higher costs as a percentage of revenue as well as unfavorable foreign currency impacts. Raw material price increases have had a negative impact on results quarter over quarter. This is impacting the chemical industry broadly as the Chinese government has been shutting down industrial parks as part of their environmental program. These shutdowns have limited the supply of certain active ingredients and intermediates, causing shortages of materials, and in certain cases, rising raw material costs. Partially offsetting the decrease was revenue growth as discussed above.

### Pro Forma Combined Results - Nine Months Ended September 30, 2018 vs. 2017

Pro forma combined revenue of $3,185.9 million increased by approximately 9 percent versus the prior year period. Refer to the *FMC Agricultural Solutions Pro Forma Combined Revenue by Region* chart above for further discussion.

Pro forma combined segment EBITDA of $916.1 million increased approximately 9 percent compared to the prior year period. The increase was primarily driven by revenue growth as discussed above. Additionally, costs as a percentage of revenue slightly decreased, which also impacted results positively, due to cost control and synergies as we leveraged our existing sales and back office infrastructure as well as savings across procurement and plant services. These were partially offset by higher raw material costs which have had a negative impact on results year over year. As discussed above, this is impacting the chemical industry broadly as the Chinese government has been shutting down industrial parks as part of their environmental program. So far, we have been able to mitigate and manage the impact on our ability to supply our customer due to our diversified supply chain network.

### Outlook

For 2018, full-year segment revenue is expected to be approximately $4.20 billion to $4.26 billion and full-year segment EBITDA is expected to be in the range of $1.20 billion to $1.22 billion. Full-year depreciation and amortization is expected to be approximately $144 million.

### FMC Lithium

*(in Millions)*

| 2018 | Three Months Ended September 30, | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Segment Revenue | $112.0 | $94.4 | $322.7 | $234.0 |
| Segment EBITDA | 48.6 | 40.2 | 150.1 | 93.7 |

### Three Months Ended September 30, 2018 vs. 2017

Revenue of $112.0 million increased by approximately 19 percent versus the prior-year quarter, primarily driven by higher volumes particularly in lithium hydroxide. Higher volumes impacted revenue by approximately 17 percent while higher pricing contributed approximately 2 percent to the revenue increase. Foreign currency had minimal impact on the change in revenue.

EBITDA of $48.6 million increased approximately $8 million versus the year ago quarter. The higher volumes and favorable pricing noted above impacted results by approximately $9 million and $1 million, respectively. These were offset by higher overall costs of approximately $2 million. Foreign currency had a minor impact on the change in EBITDA.

### Nine Months Ended September 30, 2018 vs. 2017

Revenue of $322.7 million increased by approximately 38 percent versus the prior-year period, driven by higher volumes as a result of the new lithium hydroxide production in China and our higher production in Argentina, and higher prices particularly in lithium hydroxide and butyllithium. Higher volumes impacted revenue by 23 percent and higher pricing contributed 15 percent to the revenue increase. Foreign currency had a minimal impact on the change in revenue.

EBITDA of $150.1 million increased approximately $56 million versus the year ago quarter. The favorable pricing and higher volumes noted above impacted results by approximately $33 million and $25 million, respectively. These were offset by higher overall costs of approximately $2 million. Foreign currency had a minimal impact on the change in EBITDA.

### Outlook

Segment EBITDA is expected to be between $193 million and $197 million for the full year of 2018, an increase of 37 percent over 2017 at the mid-point of the range. Full-year depreciation and amortization is expected to be approximately $19 million.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).

### Three Months Ended September 30, 2018 vs. 2017

Corporate and other expenses of $29.7 million in the three months ended September 30, 2018 increased by $7.3 million from $22.4 million in the same period in 2017. The increase was primarily driven by negative foreign currency impacts of approximately $6 million, which was mainly due to the foreign exchange impacts on intercompany fund movements which is largely not expected to repeat.

### Nine Months Ended September 30, 2018 vs. 2017

Corporate and other expenses of $80.5 million in the nine months ended September 30, 2018 increased by $11.0 million from $69.5 million in the same period in 2017. The increase was primarily driven by negative foreign currency impacts of approximately $6 million as discussed above. Additionally, the nine months ended September 30, 2018 includes approximately $3 million of LIFO expense compared to zero in the prior year period. These were offset by lower corporate shared costs of approximately $2 million.

#### Depreciation and amortization

### Three Months Ended September 30, 2018 vs. 2017

Depreciation and amortization of $42.4 million increased $17.3 million as compared to the third quarter in 2017 of $25.1 million. $18.4 million of the increase was due to the increase in intangible assets and property, plant and equipment acquired as a result of the DuPont Crop Protection Business, offset by a decrease in Corporate depreciation and amortization.

### Nine Months Ended September 30, 2018 vs. 2017

Depreciation and amortization of $124.7 million increased $53.5 million as compared to the prior year period of $71.2 million. $52.7 million of the increase was due to the increase in intangible assets and property, plant and equipment acquired as a result of the DuPont Crop Protection Business.

#### Interest expense, net

### Three Months Ended September 30, 2018 vs. 2017

Interest expense, net of $33.4 million increased compared to the third quarter in 2017 of $18.4 million. The increase was driven by interest on the 2017 Term Loan Facility of approximately $8 million. The additional increase of approximately $5 million was due to less interest allocated to discontinued operations in 2018 due to the divestment of the FMC Health and Nutrition business to DuPont in 2017. Interest was previously allocated in accordance with relevant discontinued operations accounting guidance.

### Nine Months Ended September 30, 2018 vs. 2017

Interest expense, net of $101.7 million increased compared to the prior year period of $51.3 million. The increase was driven by the addition of the 2017 Term loan Facility which increased interest expense by approximately $35 million. The remaining increase of approximately $15 million was due to less interest allocated to discontinued operations in 2018 due to the divestment of the FMC Health and Nutrition business to DuPont in 2017. Interest was previously allocated in accordance with relevant discontinued operations accounting guidance.

#### Corporate special charges (income)

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges and asset disposals | $25.1 | $4.4 | $106.6 | $7.1 |
| Other charges (income), net | 0.8 | 2.7 | (77.4) | 15.2 |
| **Total restructuring and other charges (income)** | **$25.9** | **$7.1** | **$29.2** | **$22.3** |

### Three Months Ended September 30, 2018 vs. 2017

Restructuring and asset disposal charges in 2018 of $25.1 million primarily consists of restructuring charges within FMC Agricultural Solutions associated with the integration of the DuPont Crop Protection Business. There were $14.9 million of charges incurred as a continuation of our decision to exit the Ewing R&D center. Additionally, $1.8 million of restructuring charges relate to a continuation of charges as a result of the previously disclosed change in our market access model in India. Refer to Note 9 for more information on these restructuring items. Other restructuring charges within FMC Agricultural Solutions as we continue to integrate the acquired DuPont Crop Protection Business totaled to $3.3 million.

Restructuring and asset disposal charges in 2017 of $4.4 million were primarily associated with impairment charges on intangible assets within both FMC Agricultural Solutions and Corporate.

Other charges, net in 2018 of $0.8 million consists of $2.4 million of environmental related charges for remediation activities and $0.6 million of other charges associated with the divestment of a joint venture within FMC Agricultural Solution. These charges are offset by a net gain of $2.2 million on the sale of certain products of our India portfolio to Crystal Crop Protection Limited and a portion of our European herbicide portfolio to Nufarm Limited, required by regulatory authorities as part of closing conditions for the DuPont acquisition. Refer to Note 9 and Note 4 for more information.

Other charges, net in 2017 of $2.7 million were composed of environmental related charges.

#### Non-operating pension and postretirement charges (income)

The income for the three months ended September 30, 2018 was $1.2 million compared to income of $3.6 million for the three months ended September 30, 2017. The decrease in income was primarily due to a lower expected return on plan assets of $4.0 million. See Note 15 to the condensed consolidated financial statements included in this Form 10-Q for more information.

#### Transaction-related charges

A detailed description of the transaction-related charges is included in Note 19 to the condensed consolidated financial statements included within this Form 10-Q.

### Nine Months Ended September 30, 2018 vs. 2017

Restructuring and asset disposal charges in 2018 of $106.6 million consists of restructuring charges within FMC Agricultural Solutions associated with the integration of the DuPont Crop Protection Business. These charges primarily consisted of $57.2 million of charges related to the change in our market access model in India and $27.5 million of charges due to our decision to exit the Ewing R&D center as discussed above. Refer to Note 9 for more information. Other restructuring charges within FMC Agricultural Solutions as we continue to integrate the acquired DuPont Crop Protection Business totaled to $7.9 million.

Restructuring and asset disposal charges in 2017 were primarily associated with impairment charges of intangible assets within both FMC Agricultural Solutions and Corporate of $4.4 million. Additionally, there was $2.7 million of other Corporate charges.

Other income, net in 2018 of $77.4 million primarily consists of income from the gain on sale of $87.2 million from the divestment of a portion of FMC's European herbicide portfolio to Nufarm Limited and certain products of our India portfolio to Crystal Crop Protection Limited. These divestitures satisfied FMC's commitment to the European Commission and the Competition Commission of India, respectively, for regulatory requirements in order to complete the DuPont Crop Protection Acquisition. The remaining other charges represents $9.2 million of environmental related charges for remediation activities and $0.6 million of other charges associated with the divestment of a joint venture within FMC Agricultural Solution.

Other charges (income), net in 2017 of $15.2 million were primarily related to $8.3 million of environmental related charges. Other charges (income), net also included $4.7 million of exit costs resulting from the termination and deconsolidation of a variable interest entity that was previously consolidated and was part of our FMC Agricultural Solutions segment. Additionally, we had $2.2 million of charges related to Corporate.

#### Non-operating pension and postretirement charges (income)

The income for the nine months ended September 30, 2018 was $0.5 million compared to income of $12.3 million for the nine months ended September 30, 2017. The decrease in income was primarily due to a lower expected return on plan assets of $12.1 million. See Note 15 to the condensed consolidated financial statements included in this Form 10-Q for more information.

#### Transaction-related charges

A detailed description of the transaction-related charges is included in Note 19 to the condensed consolidated financial statements included within this Form 10-Q.

#### Provision for income taxes

A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Singapore and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States or foreign withholding taxes have not been previously accrued.

### Three Months Ended September 30, 2018 vs. 2017

Provision for income taxes for the three months ended September 30, 2018 was $30.1 million resulting in an effective tax rate of 27.5 percent. Provision for income taxes for the three months ended September 30, 2017 was a benefit of $11.6 million resulting in an effective tax rate of negative 19.6 percent. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 16 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Three Months Ended September 30, 2018 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $109.6 | $30.1 | 27.5% | $59.3 | $(11.6) | (19.6)% |
| Corporate special charges | 49.7 | 10.4 |  | 52.3 | 17.9 |  |
| Tax adjustments (1) |  | (17.3) |  |  | 9.4 |  |
| **Non-GAAP - Continuing operations** | **$159.3** | **$23.2** | **14.6%** | **$111.6** | **$15.7** | **14.1%** |

(1) Refer to Note 3 of the *Adjusted Earnings Reconciliation* table within this section of this Form 10-Q for an explanation of tax adjustments.

The primary drivers for the increase in the year-to-date effective tax rate for 2018 compared to 2017 are shown in the table above. The remaining change was due to the integration of the DuPont Crop Protection Business into our global supply chain as well as the effect of the global intangible low-taxed income (GILTI) provisions of the Act.

### Nine Months Ended September 30, 2018 vs. 2017

Provision for income taxes for the nine months ended September 30, 2018 was $100.4 million resulting in an effective tax rate of 17.3 percent. Provision for income taxes for the nine months ended September 30, 2017 was $1.1 million resulting in an effective tax rate of 0.7 percent. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 16 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Nine Months Ended September 30, 2018 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $581.5 | $100.4 | 17.3% | $165.7 | $1.1 | 0.7% |
| Corporate special charges | 177.8 | 40.3 |  | 88.7 | 30.4 |  |
| Tax adjustments (1) |  | (15.4) |  |  | 2.8 |  |
| **Non-GAAP - Continuing operations** | **$759.3** | **$125.3** | **16.5%** | **$254.4** | **$34.3** | **13.5%** |

(1) Refer to Note 3 of the *Adjusted Earnings Reconciliation* table within this section of this Form 10-Q for an explanation of tax adjustments.

The primary drivers for the increase in the year-to-date effective tax rate for 2018 compared to 2017 are shown in the table above. The remaining change was due to the integration of the DuPont Crop Protection Business into our global supply chain as well as the effect of the global intangible low-taxed income (GILTI) provisions of the Act.

#### Discontinued operations, net of income taxes

Our discontinued operations, in periods up to its sale on November 1, 2017, represent the results of our discontinued FMC Health and Nutrition as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

### Three Months Ended September 30, 2018 vs. 2017

Discontinued operations, net of income taxes representing a loss of $4.7 million for the three months ended September 30, 2018 increased compared to a loss of $15.1 million for the three months ended September 30, 2017 primarily due to a $16.3 million, net of tax, environmental remediation charge for one of our sites in the prior period. Additionally, the 2017 period included results of our discontinued FMC Health and Nutrition segment. Refer to Note 11 to the condensed consolidated financial statements included within this Form 10-Q for further information.

### Nine Months Ended September 30, 2018 vs. 2017

Discontinued operations, net of income taxes representing loss of $4.2 million for the nine months ended September 30, 2018 increased compared to a loss of $157.3 million for the nine months ended September 30, 2017. The results for the nine months ended September 30, 2017 include an impairment charge of approximately $168 million ($148 million, net of tax) to write down our Omega-3 business to its estimated fair value less cost to sell. Refer to Note 11 to the condensed consolidated financial statements included within this Form 10-Q for further information.

#### Net income (loss) attributable to FMC stockholders

### Three Months Ended September 30, 2018 vs. 2017

Net income attributable to FMC stockholders increased to $72.8 million from $55.2 million in the prior-year quarter. The increase was primarily driven by higher earnings as a result of the DuPont Crop Protection Business, which was completed on November 1, 2017.

### Nine Months Ended September 30, 2018 vs. 2017

Net income attributable to FMC stockholders increased to $469.7 million from income of $5.7 million in the prior-year period. The increase was primarily due to the impairment charge, associated with our Omega-3 business, which was recorded to discontinued operations in 2017 as discussed above. The increase was also driven by higher earnings as a result of the DuPont Crop Protection Business, which was completed on November 1, 2017.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2018 and December 31, 2017, were $176.5 million and $283.0 million, respectively. Of the cash and cash equivalents balance at September 30, 2018, $168.6 million were held by our foreign subsidiaries. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries’ operating activities and future foreign investments. We have not provided additional income taxes for any additional outside basis differences inherent in our investments in subsidiaries because the investments are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings not subject to the transition tax and additional outside basis difference in these entities (i.e., basis difference in excess of that subject to the one-time transition tax) is not practicable or in process and not yet complete. We are still in the process of analyzing the impact of the Act on our indefinite reinvestment assertion.

Pursuant to the terms of the separation and distribution agreement, on October 18, 2018, we received a net distribution of approximately $320 million from Livent representing the proceeds from the sale of its common stock as part of the IPO, net of underwriting discounts and commissions and other offering related expenses. On October 31, 2018, we used $150 million of those proceeds to further pay down term loan debt. This increases our cumulative debt reduction this year to approximately $600 million.

At September 30, 2018, we had total debt of $2,742.7 million as compared to $3,185.6 million at December 31, 2017. Total debt included $2,593.3 million and $2,993.0 million of long-term debt (excluding current portions of $83.6 million and $101.2 million) at September 30, 2018 and December 31, 2017, respectively. As of September 30, 2018, we were in compliance with all of our debt covenants. See Note 10 in the condensed consolidated financial statements included in this Form 10-Q for further details.

Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, decreased from $192.6 million at December 31, 2017 to $149.4 million at September 30, 2018.

Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At September 30, 2018, we had no borrowings under the commercial paper program.

### Statement of Cash Flows

*Cash provided (required) by operating activities of continuing operations was $460.9 million and $272.5 million for the nine months ended September 30, 2018 and 2017, respectively.*

The table below presents the components of net cash provided (required) by operating activities of continuing operations.

*(in Millions)*

| 2018 | Nine Months Ended September 30, | 2017 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, non-operating pension and postretirement charges (income), interest expense, net and income taxes | $682.6 | $204.5 |
| Corporate special charges and depreciation and amortization (1) | 302.5 | 159.9 |
| **Operating income before depreciation and amortization (Non-GAAP)** | **$985.1** | **$364.4** |
| Change in trade receivables, net (2) | 91.7 | 286.8 |
| Change in inventories (3) | (110.5) | (108.1) |
| Change in accounts payable (4) | 92.7 | 104.6 |
| Change in accrued customer rebates (5) | 304.4 | 123.6 |
| Change in advance payments from customers (6) | (350.0) | (233.6) |
| Change in all other operating assets and liabilities (7) | (201.4) | (92.7) |
| **Cash basis operating income (Non-GAAP)** | **$812.0** | **$445.0** |
| Restructuring and other spending (8) | $(17.0) | $(4.2) |
| Environmental spending, continuing, net of recoveries (9) | (9.2) | (11.5) |
| Pension and other postretirement benefit contributions (10) | (34.1) | (51.1) |
| Net interest payments (11) | (98.4) | (57.6) |
| Tax payments, net of refunds (11) | (103.3) | (12.9) |
| Transactional-related legal and professional fees (12) | (89.1) | (35.2) |
| **Cash provided (required) by operating activities of continuing operations** | **$460.9** | **$272.5** |

55

(1) Represents the sum of corporate special charges and depreciation and amortization.

(2) The change in cash flows related to trade receivables in 2018 was primarily due to receivable build from the acquired DuPont Crop Protection Business as we did not acquire any receivables as part of the transaction. Additionally, timing had an impact as collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks. During the nine months ended September 30, 2018, we collected approximately $617 million of receivables in Brazil. A significant portion of the collections in Brazil are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivable balance.

(3) Inventory changes and the seasonal nature of the business within the different hemispheres are adjusted accordingly to take into consideration the change in market conditions primarily in FMC Agricultural Solutions.

(4) The change in cash flows related to accounts payable is primarily due to payable build from the acquired DuPont Crop Protection Business as we did not acquire any payables as part of the transaction, as well as timing of payments made to suppliers and vendors.

(5) These rebates are associated with our FMC Agricultural Solutions segment in North America and Brazil and generally settle in the fourth quarter of each year. The changes year over year are associated with the mix in sales eligible for rebates and incentives in 2018 compared to 2017 and timing of rebate payments. Additionally, the change in accrued rebates for 2018 was primarily due to build from the acquired DuPont Crop Protection Business as we did not acquire any accrued rebates as part of the transaction.

(6) Advance payments are primarily associated with our FMC Agricultural Solutions business within North America and these payments are received in the fourth quarter of each year and recorded as deferred revenue on the balance sheet at December 31. Revenue associated with advance payments is recognized, generally in the first half of each year, as shipments are made and control to the customer takes place.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to vendors under our vendor finance program. Additionally, the 2018 period includes the effects of the unfavorable contracts amortization of approximately $66 million.

(8) See Note 9 in our condensed consolidated financial statements included in this Form 10-Q for further details.

(9) Included in the period presented are environmental charges for environmental remediation at our operating sites of $9.2 million and $8.3 million, respectively. The amounts in 2018 will be spent in future years. The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) There were $30.0 million in voluntary contributions to our U.S. qualified defined benefit plan in the periods presented in 2018 and $44.0 million in 2017.

(11) Amounts shown in the chart represent net payments of our continuing operations. Net interest payments of $15.1 million and tax payments, net of refunds of $8.1 million were allocated to discontinued operations for the nine months ended September 30, 2017.

(12) 2018 activity represents payments for legal and professional fees primarily associated with the DuPont's Crop Protection Business Acquisition. See Note 4 to the condensed consolidated financial statements included in this Form 10-Q for more information.

*Cash provided (required) by operating activities of discontinued operations was $(46.9) million and $47.0 million for the nine months ended September 30, 2018 and 2017, respectively.*

Cash provided (required) by operating activities of discontinued operation is directly related to environmental, other postretirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. Amounts in 2017 also include operating activities related to our discontinued FMC Health and Nutrition segment.

*Cash provided (required) by investing activities of continuing operations was $(22.5) million and $(70.0) million for the nine months ended September 30, 2018 and 2017, respectively.*

The decrease in cash required during the nine months ended September 30, 2018, as compared to the same period in 2017 was primarily due to proceeds from the sales of our product portfolios of approximately $88 million that were required to complete the DuPont Crop Protection Business Acquisition, offset by higher capital expenditure spending in 2018 as well as incremental capitalizable corporate level spending associated with the implementation of a new SAP system.

*Cash provided (required) by investing activities of discontinued operations was $(15.0) million and $20.2 million for the nine months ended September 30, 2018 and 2017.*

Cash required by investing activities of discontinued operations for the nine months ended September 30, 2018 represents the working capital payment associated with the divestiture of FMC Health and Nutrition. Cash provided by investing activities of discontinued operations for the nine months ended September 30, 2017 includes proceeds from the sale of the Omega-3 business for $38.0 million, partially offset by capital expenditures of FMC Health and Nutrition.

*Cash provided (required) by financing activities was $(485.5) million and $(244.3) million for the nine months ended September 30, 2018 and 2017, respectively.*

The change period over period in financing activities is partially due to higher repayments of long-term debt in the current period of approximately $100 million compared to the prior-year period. Additionally, there were no proceeds of borrowings of long-term debt in the current period compared to $103.3 million in the prior period.

### Other potential liquidity needs

Our cash needs outside of the DuPont Crop Protection Business related integration expenses for 2018 as well as costs to separate FMC Lithium include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2018, our remaining borrowing capacity under our credit facility was $1,298.3 million (which includes borrowing capacity under our commercial paper program).

Projected 2018 capital expenditures as well as expenditures related to contract manufacturers are expected to be approximately $225 million, at the midpoint of the range, primarily driven by the lithium expansion as well as expenditures from the recently acquired DuPont Crop Protection Business. Additionally, corporate level spending includes approximately $70 million associated with the two-year implementation of a new SAP system.

As a result of the United States' enactment of the Act, we will pay a transition tax of $202.7 million which is payable over the next eight years.

Projected 2018 spending includes approximately $60 million to $65 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary cash contributions of $30.0 million during 2018. These contributions are in excess of the minimum requirements. We do not expect to make any further contributions to our U.S. defined benefit pension plan during 2018.

For the nine months ended September 30, 2018 and 2017, we paid dividends of $66.9 million and $66.6 million, respectively. On October 18, 2018, we paid dividends totaling $22.3 million to our shareholders of record as of September 28, 2018. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2018.

During the nine months ended September 30, 2018, no shares were repurchased under the publicly announced repurchase program. At September 30, 2018, $238.8 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We plan to repurchase $200 million in shares by December 31, 2018 as part of the repurchase program. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 18 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2017 can be found in a table included within Part II, Item 7 of our 2017 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2018.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2017 Form 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair Value Measurements

See Note 17 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2018, our financial instrument position was a net asset of $1.8 million compared to a net asset of $4.4 million at December 31, 2017. The change in the net financial instrument position was primarily due to change in exchange rates.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among electricity and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and electricity. To analyze the effect of changing energy prices, we perform a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2018 and December 31, 2017, with all other variables (including interest rates) held constant. Note, as of September 30, 2018 and December 31, 2017, we had no open commodity contracts. As a result, there was no sensitivity analysis performed over commodity price risk for the periods presented.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the Euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts and options are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts and options are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2018 and December 31, 2017, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets | 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at September 30, 2018** | $1.2 | $29.3 | $(30.3) |
| **Net asset (liability) position at December 31, 2017** | $4.4 | $10.8 | $(3.2) |

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. In the quarter ended September 30, 2018, we had outstanding contracts in place to swap portions of our variable-rate debt to fixed-rate debt with an aggregate notional value of $200.0 million. There were no interest rate swap agreements as of December 31, 2017.

To analyze the effects of changing interest rates, we have performed a sensitivity analysis in which we assume an instantaneous one percent change in the interest rates from their levels at September 30, 2018, with all other variables held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets | 1% Increase | 1% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at September 30, 2018** | $0.6 | $3.5 | $(2.4) |

58

Our debt portfolio, at September 30, 2018, is composed of 50 percent fixed-rate debt and 50 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2017 Term Loan Facility, 2014 Term Loan Facility, Revolving Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2018, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $10.3 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $10.3 million for the nine months of September 30, 2018.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,906 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2018, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2018, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors

FMC Corporation:

#### Results of Review of Interim Financial Information

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries (the Company) as of September 30, 2018, the related condensed consolidated statements of income (loss) and the condensed consolidated statements of comprehensive income (loss) for the three-month and nine-month periods ended September 30, 2018 and 2017, the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2018 and 2017, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2017, and the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2018, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2017, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

#### Basis for Review Results

This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

November 6, 2018

## Risk factors

As filed, 847 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A "Risk Factors" of our 2017 Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended December 31, 2017 and the Company’s other filings with the SEC, which are available at www.sec.gov and on the Company’s website at www.fmc.com.

### Forward-Looking Information

We wish to caution readers not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date made. We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Filed Nov 6, 2018.
Source: SEC EDGAR, the filing index for accession 0000037785-18-000076. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
